SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  RESOURCE CENTER  
  JOBS  
  SUBSCRIBE  
 RSS
  Monday, March 22, 2010 SEARCH     
 
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND
 
MORE FEATURES
EDC uptake in Australia lags
Narayan Kulkarni
Australian clinical trial companies to adopt electronic solutions
After 75 years, US all set to revamp its $2.5 trillion healthcare system
Narayanan Suresh
The US Senate has voted on November 22 to open a full-fledged debate on President Barack Obamas most ambitious plan to overhaul the nations healthcare system which will cost more than $1.2 trillion in the next 10 years.
MOST READ FEATURES
Primary healthcare sector in China surges ahead
Tan Shen Leng
The Chinese urban primary healthcare is rapidly growing and offers vast opportunities for healthcare suppliers and distributors in China
India to monitor CROs closely
Shruthi Ram
In an effort to give a conducive business environment to CROs in the country the Indian regulatory agency has released draft rules for mandatory registration of all Clinical Research Organizations (CRO) across the country
TODAY'S NEWS
  Valeant to buy branded generics company in Brazil
  Chugai files for anti-cancer agents Herceptin, Xeloda
  Aurobindo gets Canadian nod for for Topiramate Tablets
  Strides to acquire 100% interest in oncology JVs
  PPD, SRI sign agreement for vax clinical research services
  ABRAXANE meets primary endpoint in phIII trial for advanced NSCLC
 
Advertisement
 
Digital Mag
Read on some of the best articles published in 2009

Issue: February, 2010
Current Issue
View / Download
Top Story
India puts bt brinjal on hold
 
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement











 

FEATURES
 
'Own brand labeling' to boost medical device industry
With so many medical device makers looking further afield for opportunities to expand their businesses, some have turned their attention to a supply strategy known as own brand labeling, which is said to speed up processes and improve profitability
 
EDC uptake in Australia lags
Australian clinical trial companies to adopt electronic solutions
 
After 75 years, US all set to revamp its $2.5 trillion healthcare system
The US Senate has voted on November 22 to open a full-fledged debate on President Barack Obamas most ambitious plan to overhaul the nations healthcare system which will cost more than $1.2 trillion in the next 10 years.
 
Primary healthcare sector in China surges ahead
The Chinese urban primary healthcare is rapidly growing and offers vast opportunities for healthcare suppliers and distributors in China
 
India to monitor CROs closely
In an effort to give a conducive business environment to CROs in the country the Indian regulatory agency has released draft rules for mandatory registration of all Clinical Research Organizations (CRO) across the country
 
Clinical development trends in APAC in recessionary environment
With green shoots (recovery from the economic downturn) appearing in the global economy, it is a good time to consider what is happening in the Asia Pacific (APAC) biopharma scene
 
Healthcare infrastructure supports CRO growth in Asia
Considering the opportunity and need, the expenditure on healthcare has been on the rise in the region. In addition to the government support, private players are investing a lot in setting up good healthcare infrastructure
 
Vaxine trials show 1st swine flu vaccine works
The initial results from the clinical trials of the worlds first recombinant vaccine against swine flu, developed by a small South Australian biotech company, Vaxine Pty Ltd, indicates that the vaccine is working well in humans.
 
BioSpectrumAsia Top 20: Cochlear, 18
Cochlear is one of the worlds most innovative hearing aid companies. In 2008, it had sales of $468.61 million by selling over 18,000 implants retaining a market share of 70 percent
 
Asian CMOs in demand
Asia never had it so good. MNC pharma companies are de-risking their R&D manufacturing by outsourcing it to Asian contract research and manufacturing companiesin turn effecting substantial cost savings and keeping their faith in Asian capabilities
More
 
Advertisement





 
   
 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Jobs at CyberMedia | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[DQ Channels]  [The DQweek]  [DARE]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black